CROI 2019 Abstract eBook

Abstract eBook

Keyword Index

Fetal brain 430 Fetal growth 750 FGF-21 685 FIB-4 90, 607, 900 Fibrosis 90, 395, 607, 617, 900 Fiebig stage 522

HCV antibody avidity 601 HCV care continuum 563, 574, 578, 579, 580, 581, 582, 588 HCV clearance 86 HCV core antigen 585 HCV infection 584, 586 HCV infection; DAA; relapse; non-response 560, 564, 600, 611 HCV reinfection 85, 86, 577 HDACi 26, 372, 397, 438 Health and demographic surveillance system 146 Health center 536 Health disparities 666 Health facility 924 Health related quality of life 985 Health services research 666 Healthcare 1079 Hearing loss 740, 1013 Heart 256, 667 Hematopoietic stem cell transplantation 394 Hepatic decompensation 568 Hepatitis 618 Hepatitis A virus 619, 620, 621 Hepatitis B 606 Hepatitis B vaccine 622, 623 Hepatitis B virus 41, 219, 604, 610, 613, 624, 626, 627, 629, 839 Hepatitis C treatment 86, 87, 89, 560, 561, 563, 565, 566, 567, 574, 575, 576, 579, 587, 590 Hepatitis C virus 88, 89, 562, 563, 567, 568, 569, 572, 575, 579, 583, 584, 585, 589, 590, 593, 594, 595, 596, 597, 598, 599, 603, 604, 608, 609, 612, 614, 659, 687, 892 Hepatitis C virus kinetics 89 Hepatocellular carcinoma 90, 572, 608, 609 Hepatocytes 91, 612 Heterogeneity 176, 1054 Heterosexual couples 928 Heterosexual transmission 1060, 1086 HetIL-15 355 High-resolution anoscopy 282 Highly treatment experienced 550 Highly-sensitive C reactive protein 635 Hispanic 844 Histone deacetylase inhibitor 26 HIV • Acquisition 234, 797, 846, 999 • Adherence 1032, 1058 • and Diabetes 684 • Cancer risk 276, 817 • Clinic 927, 1049 • Coinfection 563, 576, 580, 604, 606, 614, 626, 627, 855, 894 • Comorbidity 615, 662, 1064 • Controllers 508 • Cure 24, 27, 29, 37, 354, 136, 210, 355, 356, 364, 394, 405, 379, 389, 396, 800 • Dementia 423, 434 • Diagnosis 782 • Diagnostic algorithm 556, 847 • DNA and cell-associated RNA 252 • DNA reservoir 803 • Drug resistance 525, 531, 534, 538, 864, 905 • Early infant diagnosis 779 • Entry 187 • Epidemic 861, 1049 • Eradication 337, 362, 438 • Exposed children 42, 259, 791, 779 • Exposed uninfected children 744, 751, 784, 785, 786, 787, 790, 793, 794, 795 • Immunology 221, 222, 256, 320, 360 • Incidence 48, 773, 774, 832, 834, 838, 944, 945, 1088 • Infected men who have sex with men 85, 86, 599

• Related comorbidities 15, 256, 660 • Replication 178, 191, 490

• Reservoir 43, 135, 244, 264, 265, 328, 329, 330, 332, 333, 335, 337, 343, 361, 362, 363, 365, 371, 387, 396, 398, 400, 452, 433, 727

• Resistance testing 895 • Risk behavior 844, 982 • RNA suppression 1058 • RNA testing 559 • Self-testing 93, 926, 933, 934, 936 • Serotype 885 • Specific response 320 • Surveillance 847, 861, 895 • Testing 729, 783, 918, 924, 928, 931, 936 • Testing yield 94 • Transmission 93, 843, 849, 912 • Transmission clusters 861, 863, 875 • Transmission risk 833, 887, 1000, 1060 • Treatment 1009 • Treatment outcomes 1039, 1065 • Vaccine 295, 318, 320 • Viral evolution 869, 1092 • Viral load 712, 849, 890, 1049, 1058 • Viremia 90 • Virologic failure 1045 HIV-1 specific T cells 302 HIV-1 subtype c 875 HIV-1/-2 dual infection 556 HIV-2 373, 553, 556, 922 HIV/HBV coinfection 91, 607, 625 HIV/HCV coinfection 469, 578, 915 HIV/HPV coinfection 277 HLA 190 HLA-DR 263 Home testing 54, 777, 927, 1027 Homeless individuals 891, 1062 Hormonal contraception 52, 234, 473, 998 Hospitalized patients 151 Host factors 70, 71, 332 Host mechanism 387 Host restriction factors 172, 186 Host-pathogen interaction 70, 71, 236 Housing status 1057

Financial micro-incentives 54 Fishing community 959, 1074 Flow cytometry 176, 183, 259, 316, 318 Folate 749 Follicular cytotoxic T cells 351 Follicular dendritic cell 196, 360 Fostemsavir 483, 548 Fracture 30, 686 Frailty 418, 686, 702 Fras1 extracellular matrix 1 (FREM1) 235 FTY720 133 Full-length envelope 327, 452 Full-length sequencing 347, 348, 382, 613 Fungal products 245 Fusion 172 Fusion inhibitors 182 Gag 178

GALT 205, 335, 343, 398 Gamma delta T cell 254 Gardnerella vaginalis 238 GB Virus C 296 GC TFH 130

Gender 517, 901 Gene editing 353 Gene expression 281, 400 Gene therapy 24, 25 Generalized estimating equation 762 Generalized linear model 877, 879 Generics 739 Genetic distance threshold 856

Genetic interaction 185 Genetic variability 690 Genetically Intact HIV 382 GeneXpert MTB/RIF Ultra 741 Genital 293, 1001 Genital tract HIV RNA 50, 337 Genotype susceptibility 532 Genotypes 595, 623 Genotypic susceptibility 535 Genotyping 895 Geospatial analysis 863, 876 Germinal center 381 Global 563 Global deficit score 421 Glycosylation 124, 304, 385, 386 Gonorrhea 852, 853 gp120 653 gp41 310 Grazoprevir 468 Grazoprevir/Elbasvir 561, 562 Growth 790, 791, 792, 794, 815 Growth curves 793 GS-9131 482 GSK2838232 142 GSS 547

HPTN 074 534 HPTN 078 912 HPV 276, 279, 282, 283 HSIL 282

HSV-2 1004 HTLV-1 894 Human herpesvirus 8 17, 635

Human papillomavirus infection 278, 284 Human papillomavirus vaccine 14, 284 Humanized mice 363, 630 Humanized mouse model 188, 219, 354, 433, 475, 488 Humans 475 Hypercholesterolemia 666 Hypertension 666, 668 Ibalizumab 485 ICAM-1 643 IFITM 69 IgG3 307 IL-10 631 IL-15 355, 390 IL-32 632 IL-6 37, 647, 685, 813 IL-7 726 Imaging 71, 73, 222, 479 Immediate therapy 43, 515 Immune • Activation 36, 205, 211, 244, 245, 248, 517, 634, 657, 673, 808 • Activation and inflammation 37, 171, 224, 231, 232, 236, 242, 250, 253, 263, 301, 303, 407, 569, 644, 646, 656, 814 • Cells 240, 242 • Checkpoint 316, 381 • Checkpoint blockade 132 • Correlates 770, 771 • Dysfunction 257, 291, 636 • Evasion 211 IFN 69, 167, 171, 174 IFN-alpha 136, 304 IgG 124, 801

Keyword Index

Guidelines 774 Gut biopsy 301 Gut homing 204 Gut immunology 398 Gut integrity marker 303, 569 Gut microbiome 232, 227 Gut mucosa 201, 203, 207, 227, 228, 249 GWAS 823 HAART toxicity 435 HAART-naive patients 241, 500, 1058 HAART-treated patients 174, 241, 299, 332, 500, 648, 675, 1058 Hair 766 Haiti 1017 HAND 414, 420, 423, 435 Haplogroups 702 Hazard ratio (HR) 914 HbA1c 703 HBsAg seroconversion 627 HBV 607, 623, 628, 630 HBV cure 91, 624 HBV functional cure 625 HBV reactivation 628 HCV 573, 581, 586, 601, 628

• Infected patients 142, 483, 1049 • Infected population 677, 849, 880 • Infected women 41, 765 • Inflammation 321, 632, 660 • Inhibition 480 • Latency 328, 397 • Malignancies 274, 281 • Markers 329 • Nef 188, 189, 190, 191, 192, 193, 194, 195 • Persistence 130, 304, 361 • Prevalence 842, 951 • Prevention 105, 975, 976, 979, 993 • Provirus 372, 613 • Reactivation 328, 329, 397

• Exhaustion 248, 255, 272 • Reconstitution 520, 625

CROI 2019 461